SCHEMBL19143459

SCHEMBL19143459

CCN(C(=O)c1cc2ncccc2n(C)c1=O)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.45
▸ TP53 P04637 1/20 0.45
▸ ALDH1A1 P00352 3/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ MAPT P10636 2/20 0.43
▸ KMT2A Q03164 3/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ TSHR P16473 3/20 0.41
▸ GLA P06280 1/20 0.40
▸ ADORA2A P29274 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ HDAC6 Q9UBN7 1/20 0.39
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2B6 P20813 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15197869 0.76 MEN1 (0.49) HTTTP53ALDH1A1SMN1; SMN2NPC1
SCHEMBL16735595 0.76 MET (0.54) HTTTP53ALDH1A1SMN1; SMN2NPC1
SCHEMBL30539577 0.75 SYK (0.41) TP53ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL6061273 0.75 SYK (0.41) TP53ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL2462559 0.69 ALDH1A1 (0.58) HTTTP53ALDH1A1SMN1; SMN2NPC1
SCHEMBL29972879 0.69 KMT2A (0.71) TP53ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL1446261 0.69 KMT2A (0.71) TP53ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL17440399 0.69 DAO (0.56) HTTTP53ALDH1A1SMN1; SMN2NPC1
SCHEMBL16735626 0.68 PDK1 (0.46) TP53SMN1; SMN2NPC1RAB9ACYP3A4
SCHEMBL30910934 0.67 ATAD2 (0.50) ALDH1A1SMN1; SMN2NPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2552915-B1 COMPOUNDS FOR THE TREATMENT OF HIV CRITICAL OUTCOME TECH INC (CA) 2017-07-19 — — EP disclosed
Send feedback